Move Beyond Traditional Licensing
When you think of licensing intellectual property, you probably picture the usual deal: an upfront fee and ongoing royalty payments. While this model has worked for years, it often limits your potential earnings. Once the contract is signed, your income depends almost entirely on the licensee’s sales performance. But in today’s fast-paced markets, where IP can drive exponential growth, you have the opportunity to capture more value.
By structuring your licensing deals with equity participation, you can go beyond collecting cash. With this approach, you’d receive a stake in the licensee’s business, turning your relationship into more than just a transaction—it becomes a partnership. You don’t just license your IP; you position yourself to benefit from the licensee’s long-term success.
The DigiAsia–Nowigence Example
Take the $6 million licensing deal between DigiAsia Corp and Nowigence as an example. Instead of settling for a traditional cash agreement, DigiAsia accepted 1.2 million shares in Nowigence in exchange for licensing its AI platform. On top of that, DigiAsia secured a perpetual, zero-cost license back, allowing them to continue using their own technology internally at no extra cost.
This deal offered DigiAsia two key benefits. First, they gained immediate equity value with the potential for significant growth if Nowigence successfully commercializes the platform. Second, they retained full access to their technology, ensuring smooth operations and ongoing innovation. By holding equity, DigiAsia became not just a licensor but also an investor with a vested interest in Nowigence’s success.
Apply Equity-Royalty Deals in Any Industry
Although the DigiAsia deal is rooted in AI, you can use equity-royalty licensing across various industries. In biotechnology, for instance, you could combine upfront fees, royalties, milestone payments, and equity stakes, ensuring you share in both the development and the commercial success of new therapies.
In media and entertainment, you might negotiate a share of advertising revenue, streaming royalties, or box office performance, while also taking an equity position in production companies or platforms. Similarly, in software and technology, you could pair licensing with stock options, equity notes, or warrants, giving you a stake in future funding rounds or exits. Even in consumer products, you can combine royalty payments with equity stakes to profit from brand expansion and product line success.
Why Equity-Royalty Models Work for You
Equity-royalty licensing aligns your goals with your licensee’s. Both of you are motivated to maximize the potential of your IP because success benefits everyone involved. For you, this model diversifies income: you get steady royalties for cash flow and equity for long-term growth tied to the licensee’s business. Instead of stepping aside once the deal is signed, you stay actively involved in your IP’s success.
Equity participation also has the potential to deliver far greater returns. If the licensee grows rapidly, enters new markets, or gets acquired, you benefit directly as a shareholder. At the same time, the royalty component ensures you capture value even if the equity takes time to grow. This dual strategy combines short-term income with long-term investment potential.
What This Means for You
The DigiAsia–Nowigence deal proves that creative licensing structures can deliver much higher returns than traditional models. By combining royalties with equity, you move from being a passive recipient of payments to an active participant in your partner’s success. This strategy works in any industry and can be tailored to fit your specific goals.
If you’re an IP owner, the message is clear: licensing doesn’t have to stop at royalties. By adding equity and other value-sharing models, you can maximize your returns and build partnerships that grow with your licensee’s success.
Ready to explore how you could leverage higher returns in your IP licensing through equity, royalties, and other creative participation models? Schedule a short consulting call with us today.
And don’t miss out—sign up for our newsletter to get more insights on structuring licensing deals that go beyond the traditional.
Rand Brenner is an IP professional whose passion is helping inventors, startups, and businesses use licensing to turn their IP into income-producing products, services, and technologies. His decades of experience run the gamut from medical devices to food technology to consumer products. He’s licensed some of the biggest Hollywood entertainment blockbusters, including the Batman Movies (1 and 2) and the number one kid’s action TV show, the Mighty Morphin Power Rangers. Rand speaks about licensing and is a featured speaker at investment conferences, trade shows, colleges, and startup events. His first book, Hidden Wealth: The Money-Making Power of Licensing, was released in 2019 and is available on Amazon.com. He’s also a published writer, and his articles have appeared in several prestigious trade magazines, including The Licensing Journal, Intellectual Property Magazine, and License India.
Working Through a Licensing or Commercialization Challenge?
If you have market-ready intellectual property, a licensing campaign that has stalled, or a business opportunity that may benefit from licensing, a short strategy discussion can help clarify the next step.